Safety and Immunogenicity of a Bivalent Paratyphoid A-Typhoid Conjugate Vaccine in Healthy Indian Adults: A Phase I, Randomized, Active Controlled Study
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Article activity feed
-
Matthew Laurens
Review 3: "Safety and Immunogenicity of a Bivalent Paratyphoid A-Typhoid Conjugate Vaccine in Healthy Indian Adults: A Phase I, Randomized, Active Controlled Study"
The general consensus among reviewers was that this study was reliable, highlights important evidence for the immunogenicity for this novel vaccine, and has important implications for future clinical development.
-
Kathleen Neuzil
Review 2: "Safety and Immunogenicity of a Bivalent Paratyphoid A-Typhoid Conjugate Vaccine in Healthy Indian Adults: A Phase I, Randomized, Active Controlled Study"
The general consensus among reviewers was that this study was reliable, highlights important evidence for the immunogenicity for this novel vaccine, and has important implications for future clinical development.
-
Megan Carey
Review 1: "Safety and Immunogenicity of a Bivalent Paratyphoid A-Typhoid Conjugate Vaccine in Healthy Indian Adults: A Phase I, Randomized, Active Controlled Study"
The general consensus among reviewers was that this study was reliable, highlights important evidence for the immunogenicity for this novel vaccine, and has important implications for future clinical development.
-
Strength of evidence
Reviewers: M Carey (London School of Hygiene and Tropical Medicine) | 📗📗📗📗◻️
K Neuzil (University of Maryland) | 📗📗📗📗◻️
M Laurens (University of Maryland) | 📘📘📘📘📘 -
Strength of evidence
Reviewers: M Carey (London School of Hygiene and Tropical Medicine) | 📗📗📗📗◻️
K Neuzil (University of Maryland) | 📗📗📗📗◻️
M Laurens (University of Maryland) | 📘📘📘📘📘 -